Preliminary real-world efficacy and safety of telitacicept in pediatric immunoglobulin A nephropathy: An exploratory retrospective case series

J Int Med Res · 2026 · PMC13237265

Europe PMC

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

did not reach statistical significancep = 0.29not close (p > 0.1)

By month 6, the median UPCR further decreased to 0.15 g/g; however, this reduction did not reach statistical significance (p = 0.29).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.